Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information from Roche Products (Ireland) Limited regarding GAVRETO (pralsetinib): Increased risk for tuberculosis and measures to minimize this risk
Important Safety Information – GAVRETO (pralsetinib)